Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,498 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates.
Moser M, Bertram U, Peter K, Bode C, Ruef J. Moser M, et al. J Cardiovasc Pharmacol. 2003 Apr;41(4):586-92. doi: 10.1097/00005344-200304000-00011. J Cardiovasc Pharmacol. 2003. PMID: 12658060
Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials.
Bertram U, Moser M, Peter K, Kuecherer HF, Bekeredjian R, Straub A, Nordt TK, Bode C, Ruef J. Bertram U, et al. Among authors: moser m. J Thromb Thrombolysis. 2002 Dec;14(3):197-203. doi: 10.1023/a:1025044625487. J Thromb Thrombolysis. 2002. PMID: 12913399
ERK signaling is a central regulator for BMP-4 dependent capillary sprouting.
Zhou Q, Heinke J, Vargas A, Winnik S, Krauss T, Bode C, Patterson C, Moser M. Zhou Q, et al. Among authors: moser m. Cardiovasc Res. 2007 Dec 1;76(3):390-9. doi: 10.1016/j.cardiores.2007.08.003. Epub 2007 Aug 11. Cardiovasc Res. 2007. PMID: 17850776
HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2.
Winnik S, Klinkert M, Kurz H, Zoeller C, Heinke J, Wu Y, Bode C, Patterson C, Moser M. Winnik S, et al. Among authors: moser m. Cardiovasc Res. 2009 Aug 1;83(3):558-65. doi: 10.1093/cvr/cvp133. Epub 2009 Apr 29. Cardiovasc Res. 2009. PMID: 19403561
Krüppel-like factor 15 regulates BMPER in endothelial cells.
Helbing T, Volkmar F, Goebel U, Heinke J, Diehl P, Pahl HL, Bode C, Patterson C, Moser M. Helbing T, et al. Among authors: moser m. Cardiovasc Res. 2010 Feb 1;85(3):551-9. doi: 10.1093/cvr/cvp314. Epub 2009 Sep 17. Cardiovasc Res. 2010. PMID: 19767294 Free PMC article.
Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.
Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M. Diehl P, et al. Among authors: moser m. Basic Res Cardiol. 2010 May;105(3):379-87. doi: 10.1007/s00395-009-0073-8. Epub 2009 Nov 27. Basic Res Cardiol. 2010. PMID: 19943165 Clinical Trial.
Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P, Aleker M, Helbing T, Sossong V, Beyersdorf F, Olschewski M, Bode C, Moser M. Diehl P, et al. Among authors: moser m. Interact Cardiovasc Thorac Surg. 2010 Aug;11(2):133-7. doi: 10.1510/icvts.2010.232603. Epub 2010 May 14. Interact Cardiovasc Thorac Surg. 2010. PMID: 20472650
Clopidogrel in acute coronary syndrome: implications of recent study findings.
Duerschmied D, Bode C, Moser M. Duerschmied D, et al. Among authors: moser m. Expert Rev Cardiovasc Ther. 2010 Sep;8(9):1215-29. doi: 10.1586/erc.10.104. Expert Rev Cardiovasc Ther. 2010. PMID: 20828343 Review.
Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation.
Diehl P, Halscheid C, Olivier C, Helbing T, Bode C, Moser M. Diehl P, et al. Among authors: moser m. Clin Res Cardiol. 2011 Sep;100(9):765-71. doi: 10.1007/s00392-011-0310-7. Epub 2011 Apr 9. Clin Res Cardiol. 2011. PMID: 21479772
Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study.
Duerschmied D, Ahrens I, Mauler M, Brandt C, Weidner S, Bode C, Moser M. Duerschmied D, et al. Among authors: moser m. PLoS One. 2012;7(2):e32656. doi: 10.1371/journal.pone.0032656. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384279 Free PMC article.
1,498 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback